In a report published Monday, J.P. Morgan analyst Michael Weinstein downgraded the rating on Johnson & Johnson JNJ from Overweight to Neutral, but raised the price target from $77.00 to $83.00.
In the report, Weinstein noted, “We're lowering our rating on shares of Johnson & Johnson today to Neutral from Overweight. Last June, J&J was trading at a 5% discount to the sum-of-its-parts; now the shares trade at an 8% premium after a 30% run (and $54B in increased market cap). As good as Pharma and Consumer Staples stocks have been, J&J of late has been even better; and while fundamentals have improved at J&J, at $82 we think this is much more reflected in the name.”
Johnson & Johnson closed on Friday at $82.04.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
---|
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in